Reckitt Benckiser Group (LON:RB) had its price target raised by Barclays from GBX 9,000 ($110.76) to GBX 9,400 ($115.68) in a research note issued to investors on Wednesday, Borsen Zeitung reports. The firm currently has an overweight rating on the stock.
Other research analysts also recently issued reports about the company. DZ Bank upped their price target on Reckitt Benckiser Group from GBX 7,100 ($87.37) to GBX 7,800 ($95.99) and gave the company a buy rating in a report on Thursday, May 28th. CSFB reaffirmed a neutral rating on shares of Reckitt Benckiser Group in a research note on Thursday, April 30th. Societe Generale decreased their price objective on Reckitt Benckiser Group from GBX 5,400 ($66.45) to GBX 5,200 ($63.99) and set a sell rating on the stock in a research note on Thursday, June 4th. Credit Suisse Group raised their price objective on Reckitt Benckiser Group from GBX 7,000 ($86.14) to GBX 7,200 ($88.60) and gave the stock a neutral rating in a research note on Tuesday, July 28th. Finally, Deutsche Bank reaffirmed a buy rating and issued a GBX 8,400 ($103.37) price objective on shares of Reckitt Benckiser Group in a research note on Wednesday. Two equities research analysts have rated the stock with a sell rating, four have given a hold rating and thirteen have issued a buy rating to the company’s stock. The company presently has an average rating of Buy and an average target price of GBX 7,655.56 ($94.21).
Shares of RB stock opened at GBX 7,706 ($94.83) on Wednesday. Reckitt Benckiser Group has a twelve month low of GBX 73.44 ($0.90) and a twelve month high of GBX 8,191.30 ($100.80). The stock has a market cap of $54.80 billion and a price-to-earnings ratio of -14.83. The business’s fifty day moving average is GBX 7,441.20 and its 200 day moving average is GBX 6,629.16. The company has a quick ratio of 0.40, a current ratio of 0.56 and a debt-to-equity ratio of 130.80.
The firm also recently announced a dividend, which will be paid on Tuesday, September 29th. Investors of record on Thursday, August 20th will be given a dividend of GBX 73 ($0.90) per share. This represents a dividend yield of 0.94%. The ex-dividend date of this dividend is Thursday, August 20th. Reckitt Benckiser Group’s dividend payout ratio is currently -39.06%.
In other Reckitt Benckiser Group news, insider Nicandro Durante bought 165 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was purchased at an average price of GBX 6,884 ($84.72) per share, for a total transaction of £11,358.60 ($13,978.10).
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Recommended Story: What is the S&P/ASX 200 Index?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.